Abstract
The successful synthesis and use of carrier-free radioiodinated β2-adrenergic receptor competitive antagonist photoaffinity labels (±)-[125I]IABP, (±)-[125I]MAPIT, (−)-[125I]IAPTA, and (±)-[125I]IAPCGP-12177, are described. In addition, the synthesis and use of two carrier-free radioiodinated β-adrenergic receptor agonist photoaffinity labels (±)-[125I]iodoazidoprenalterol ((±)-[125I]IAPr) and (−)-N-(p-azido-m-[125I]iodophenethylamidoisobutyl)norepinephrine ((−)-[125I]NAIN), are described. All antagonist photolabels were capable of highly specific derivatization of the purified recombinant hamster lung β2-adrenergic receptor. Tryptic cleavage of the photolabeled receptor into a 30-kDa radiolabeled fragment (transmembrane 1-5) and an 8-kDa radiolabeled fragment (transmembrane 6,7) showed variable Insertion ratios between the two juxtaposed domains, depending on the structure of the photolabel. Unique synthetic strategies were used for the agonist photolabels. The phenolic hydroxyl of (±)-IAPr was protected as the glucoside and deprotected enzymatically in the final step. The final coupling step in the synthesis of (−)-[125I]NAIN was accomplished by reductive alkylation without protection of the catechol hydroxyls of norepinephrine using sodium cyanoborohydride. (±)-IAPr was found to be a partial agonist for the turkey erythrocyte β-adrenergic receptor and an effective photoaffinity label for the avian β-adrenergic receptor. (−)-NAIN was found to be a full agonist for the β2-adrenergic receptor in guinea pig lung membranes and a highly effective agonist photoaffinity label for the β2-adrenergic receptor. These photolabels will be useful for probing the β-adrenergic receptor binding site In order to "map" this site under nonactivated (antagonist photolabels) or activated states (agonist photolabels).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.